People · Operator
Named in public records as an officer, director or promoter · active 2019–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sprout2 Inc. | — | Pharmaceuticals | Series B | $66.0M | $62.0M | 2019 |
Adele Robert Oliva at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adele Robert Oliva on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adele Oliva | 1 | 9 |
| W. Robert Dahl | 1 | 6 |
| Robert Whitehead | 1 | 5 |
| Robert Dahl | 1 | 4 |
| Cynthia Whitehead | 1 | 2 |
| Cynthia Eckert | 1 | 1 |
| Robert Robert Whitehead | 1 | 1 |
| Matthew Robert Petzold | 1 | 1 |
| Eric Atkins | 1 | 1 |
| Gail Robert Becker | 1 | 1 |
| Margaret Henry | 1 | 1 |
| Sandra Robert McGlothlin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.